114435-02-8 | 4-Fluoro-1,3-dioxolan-2-one

CAS:114435-02-8 | 4-Fluoro-1,3-dioxolan-2-one ,Description

4-Fluoro-1,3-dioxolan-2-one (4-F-1,3-dioxolan-2-one) is an organic compound with a wide range of applications in various scientific fields. It is a versatile compound that has been used in the synthesis of a variety of compounds and materials, as well as in the study of biochemical and physiological processes. 
 

Scientific Research Applications

• Materials for Lithium Batteries: 4-Fluoro-1,3-dioxolan-2-one has been successfully used in the direct fluorination of 1,3-dioxolan-2-one for applications in lithium ion secondary batteries (Kobayashi et al., 2003).
• Organic Compound Fluorination: This compound has been used in the regioselective anodic fluorination of 4-arylthio-1,3-dioxolan-2-ones, showing a marked solvent effect on fluorinated product selectivity (Ishii et al., 2001).
• Research in Ion Pair Formations: It has been employed in the study of rate constants for contact ion pair and solvent-separated ion pair formations (Ōki et al., 1998) .
• Liquid Crystal Technology: 4-Fluoro-1,3-dioxolan-2-one derivatives have been used to enhance the positive dielectric anisotropy and birefringence of tolane-liquid crystals (Chen et al., 2015).
• Fluorinated Fullerene Synthesis: It has been involved in the synthesis of fluorinated fullerene-fused 1,3-dioxolanes, contributing to the understanding of their optical properties and electronic transmission capabilities (Haonan et al., 2014).
• Lithium Anode Efficiency: The compound has been used in a binary electrolyte for lithium bis(fluorosulfonyl)imide/1,3-dioxolane, improving the suppression of lithium-dendrite growth and cycling efficiency (Zhang et al., 2018).
• Anaesthetics Research: 4-Fluoro-1,3-dioxolan-2-one derivatives have been explored as potential inhalation anaesthetics (Bagnall et al., 1977).
• Anti-HIV Drug Research: The compound has been used in the synthesis of β-d-3‘-fluoro-2‘,3‘-unsaturated nucleosides as potential anti-HIV agents (Zhou et al., 2004) .

More Information